AL-60371, 0.3% otic suspension

DRUG2 trials

Sponsors

Alcon Research

Conditions

Acute Otitis Externa

Phase 3

Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa

CompletedNCT01535560

Alcon ResearchAcute Otitis Externa

Start: 2012-04-30End: 2012-10-31Updated: 2013-12-10

Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa

CompletedNCT01535599

Alcon ResearchAcute Otitis Externa

Start: 2012-03-31End: 2013-05-31Updated: 2014-07-08